Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Paplomata
P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
Current Medicinal Chemistry
Organic Chemistry
Biochemistry
Drug Discovery
Molecular Medicine
Pharmacology
Related publications
MNK1 and MNK2 Regulation in HER2-overexpressing Breast Cancer Lines
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells With Primary Trastuzumab Resistance
Anti-Cancer Agents in Medicinal Chemistry
Cancer Research
Molecular Medicine
Pharmacology
HER2/ErbB2 Activates HSF1 and Thereby Controls HSP90 Clients Including MIF in HER2-overexpressing Breast Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Degradation of HER2/neu by ANT2 shRNA Suppresses Migration and Invasiveness of Breast Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Her2 Cross Talk and Therapeutic Resistance in Breast Cancer
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Trastuzumab-Dm1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer
The Open Breast Cancer Journal
The Role of HER2 in Early Breast Cancer Metastasis and the Origins of Resistance to HER2-targeted Therapies
Experimental and Molecular Pathology
Forensic Medicine
Pathology
Clinical Biochemistry
Molecular Biology